# Examining HIV Treatment Adherence During Early Disease

> **NCT02419066** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 904 (actual)

## Conditions studied

- Medication Adherence
- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02419066
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 904 (ACTUAL)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419066, "Examining HIV Treatment Adherence During Early Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02419066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*